Pharma Stocks Face Investor Backlash
Investors have been expressing their discontent with the financial results and corporate strategies of drugmakers in recent days. Bristol Myers Squibb (BMY) witnessed a 3.6% drop in shares following the…
Investors have been expressing their discontent with the financial results and corporate strategies of drugmakers in recent days. Bristol Myers Squibb (BMY) witnessed a 3.6% drop in shares following the…